David Pendarvis - Mar 3, 2023 Form 4 Insider Report for RESMED INC (RMD)

Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
Mar 3, 2023
Transactions value $
-$325,035
Form type
4
Date filed
3/7/2023, 11:32 AM
Previous filing
Feb 6, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$325K -1.5K -1.57% $216.69 94.2K Mar 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022.